Differential susceptibility of multidrug resistance protein-1 deficient mice to DSS and TNBS-induced colitis

The molecular mechanisms underlying inflammatory bowel diseases (IBD) are incompletely characterized. MRP-1, normally expressed in the large and small bowel epithelium, serves as a multidrug resistance protein. In this report we explored the role of MRP1 in IBD. Mrp1-deficient mice (mrp1^–/–) were subjected to two different models of IBD. The mrp1^–/– mice and wild-type (WT) mice showed equal induction of TNBS colitis, a hapten-induced T-cell mediated disease. However, in DSS colitis more severe disease was observed in mrp1^–/– mice. In a survival study, mortality of mrp1^–/– mice was higher. In nonlethal DSS colitis, the mean histological colitis score was significantly higher in mrp1^–/– mice and showed particularly severe epithelial damage. Although endogenous LTB₄ levels were significantly increased in mrp1^–/– mice, treatment with a LTB₄ antagonist did not reduce disease. We conclude that MRP-1 has an important role in the intestinal epithelial resistance to exogenous injury, but MRP-1 does not affect T-lymphocyte mediated mucosal damage.